BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10692777)

  • 1. Treatment of inflammatory bowel disease with azathioprine: how to use it in 1999.
    Louis E; Belaiche J
    Acta Gastroenterol Belg; 1999; 62(4):437-9. PubMed ID: 10692777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe life-threatening diarrhea caused by azathioprine but not by 6-mercaptopurine.
    Marbet U; Schmid I
    Digestion; 2001; 63(2):139-42. PubMed ID: 11244253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of thiopurine agents in ulcerative colitis].
    Chaparro M; Gisbert JP
    Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease.
    Present DH
    Am J Gastroenterol; 1993 May; 88(5):627-30. PubMed ID: 8480721
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicity and response to thiopurines in patients with inflammatory bowel disease.
    Goldberg R; Irving PM
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):891-900. PubMed ID: 25915575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC; Butler WJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Azathioprine, 6-mercaptopurine, and inflammatory diseases of the intestine].
    Beaugerie L; Gendre JP
    Gastroenterol Clin Biol; 1990; 14(3):230-40. PubMed ID: 2188863
    [No Abstract]   [Full Text] [Related]  

  • 12. Azathioprine pancreatitis in inflammatory bowel disease and successful subsequent treatment with mercaptopurine.
    Alexander S; Dowling D
    Intern Med J; 2005 Sep; 35(9):570-1. PubMed ID: 16105163
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is there any interest to dose the azathioprine's metabolites during inflammatory bowel diseases?].
    Melaouhia S; Fékih M; Ferchichi H; Bouissorra H; Ben Mustapha N; Boubaker J; Filali A; Lakhal M; Klouz A
    Therapie; 2013; 68(5):313-20. PubMed ID: 24225042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
    Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Azathioprine in chronic inflammatory bowel diseases. Evidence base].
    Herrlinger K; Stange EF
    Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.
    Kennedy NA; Rhatigan E; Arnott ID; Noble CL; Shand AG; Satsangi J; Lees CW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1255-66. PubMed ID: 24117596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is thiopurine therapy in ulcerative colitis as effective as in Crohn's disease?
    Ghosh S; Chaudhary R; Carpani M; Playford RJ
    Gut; 2006 Jan; 55(1):6-8. PubMed ID: 16344570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
    Dubinsky MC
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):731-43. PubMed ID: 15354273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.